BioSpace News Archive

Neurocrine Biosciences is partnering with Japan’s Takeda Pharmaceutical to develop and commercialize molecules in Takeda’s early-to-mid-stage psychiatry pipeline.

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 17, 2020.

North American feasibility study demonstrated the utility, safety and efficacy of the alfapump in the management of patients with recurrent and refractory ascites

Adial Pharmaceuticals, Inc. announced that it has received all necessary approvals to commence its landmark ONWARD™ pivotal Phase 3 clinical trial in Poland to investigate its lead drug candidate, AD04, as a therapeutic agent for the treatment of Alcohol Use Disorder in persons with certain target genotypes related to the serotonin transporter and receptor genes.

From 2018 to 2028, the global spinal fusion market would grow at a moderate pace. This would translate to a plethora of novel opportunities.

The global membrane filters market was valued at US$ 28,134.4 Mn in 2016.

The global cast saw devices market is highly fragmented, Transparency Market Research examined during their detailed study.

Growing prevalence of ophthalmic disorders such as glaucoma, age-related macular degeneration, cataract, diabetic retinopathy, refractive disorders, retinal disorders, and cataract is anticipated to drive excimer and femtosecond ophthalmic lasers market.

EUR 18m raised to date, with investors including Lifeline Ventures, Finnish private investors, the European Innovation Council and Business Finland

Supports the body’s natural healing response to facilitate new tendon-like tissue growth for rotator cuff repairs.1-5